Leprosy vaccines. 1971

B Becker

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial

Related Publications

B Becker
September 1990, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
B Becker
May 1991, Vaccine,
B Becker
March 1983, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
B Becker
January 1992, The National medical journal of India,
B Becker
January 1990, Advances in biotechnological processes,
B Becker
January 1998, Indian journal of dermatology, venereology and leprology,
B Becker
May 1987, Lancet (London, England),
B Becker
January 1987, Indian journal of leprosy,
B Becker
January 1994, The National medical journal of India,
B Becker
January 1991, Indian journal of leprosy,
Copied contents to your clipboard!